We are live on
!
Find out more
FGP
Foyston, Gordon, & Payne Portfolio holdings
AUM
$434M
1-Year Est. Return
9.09%
This Fund
S&P 500
This Quarter
Est. Return
+3.59%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$812M
AUM Growth
+$5.96M
(+0.74%)
Cap. Flow
-$26.9M
Cap. Flow
% of AUM
-3.32%
Top 10 Holdings %
Top 10 Hldgs %
32.2%
Holding
92
New
3
Increased
34
Reduced
31
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$13.4M |
| 2 |
Tidewater
TDW
|
+$9.77M |
| 3 |
Mattel
MAT
|
+$9.66M |
| 4 |
Conagra Brands
CAG
|
+$6.65M |
| 5 |
State Street
STT
|
+$5.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$22M |
| 2 |
BHI
Baker Hughes
BHI
|
+$18.4M |
| 3 |
Newell Brands
NWL
|
+$8.15M |
| 4 |
PPL
PPL Corp
PPL
|
+$7.03M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$5.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Technology | 16.93% |
| 3 | Financials | 15.18% |
| 4 | Energy | 10.88% |
| 5 | Consumer Staples | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
RTX Corp
RTX
$290B
| $606K | 0.07% |
8,239
| – | – |
|
77
IBM
IBM
$213B
| $602K | 0.07% |
3,270
| – | – |
|
78
iShares Core S&P 500 ETF
IVV
$858B
| $583K | 0.07% |
3,100
| – | – |
|
79
Abbott
ABT
$187B
| $477K | 0.06% |
12,386
-184
| -1% | -$7.09K |
|
80
US Bancorp
USB
$97.9B
| $409K | 0.05% |
9,553
| – | – |
|
81
Wells Fargo
WFC
$254B
| $369K | 0.05% |
7,421
| – | – |
|
82
JPMorgan Chase
JPM
$916B
| $271K | 0.03% |
4,471
| – | – |
|
|
CMA
83
DELISTED
Comerica
CMA
| $250K | 0.03% |
4,820
| – | – |
|
|
ACET
84
DELISTED
Aceto Corp
ACET
| $238K | 0.03% |
11,851
| – | – |
|
85
Pfizer
PFE
$143B
| $225K | 0.03% |
7,371
| – | – |
|
|
86
Berkshire Hathaway Class A
BRK.A
$1.1T
| – | – |
-31
| Closed | -$5.51M |
|
87
Dover
DOV
$26.7B
| – | – |
-68,440
| Closed | -$4.43M |
|
88
Emerson Electric
EMR
$81.6B
| – | – |
-31,640
| Closed | -$2.22M |
|
89
Exelon
EXC
$48.1B
| – | – |
-264,249
| Closed | -$5.16M |
|
90
Hasbro
HAS
$13.5B
| – | – |
-81,398
| Closed | -$4.48M |
|
|
91
Newell Brands
NWL
$2.21B
| – | – |
-251,574
| Closed | -$8.15M |
|
|
DWA
92
DELISTED
DREAMWORKS ANIMATION SKG INC CL-A
DWA
| – | – |
-79,026
| Closed | -$2.81M |
|
Similar funds
HCM
GS
IA
PAMS
SSWG
JWM
GDS
GPP
Foyston, Gordon, & Payne's Q1 2014 Portfolio in Review
As of Q1 2014, Foyston, Gordon, & Payne held 92 positions worth $812M, up 0.74% from $806M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Foyston, Gordon, & Payne withdrew a net $26.9M in Q1 2014, closing 7 positions and reducing 31 holdings. Its most notable exit was Newell Brands, an estimated $8.15M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Financials.
Against the trend, Foyston, Gordon, & Payne opened a new position in iShares Russell 2000 ETF worth $13.5M.
- Foyston, Gordon, & Payne's largest Q1 2014 buy was iShares Russell 2000 ETF: 116,200 shares worth $13.5M.
- Foyston, Gordon, & Payne added most to Tidewater in Q1 2014, an estimated $9.77M increase.
- Foyston, Gordon, & Payne's biggest Q1 2014 reduction was Teva Pharmaceuticals, cutting an estimated $22M.
- Foyston, Gordon, & Payne fully exited Newell Brands in Q1 2014, selling an estimated $8.15M.
- Foyston, Gordon, & Payne's ten largest holdings make up 32% of its $812M portfolio in Q1 2014.
- Foyston, Gordon, & Payne opened 3 new positions and closed 7 in Q1 2014.
- Foyston, Gordon, & Payne's portfolio value rose 0.74% quarter-over-quarter to $812M.
Based on Foyston, Gordon, & Payne's 13F filing for Q1 2014, filed 14 May 2014.